Skip to main content
. 2018 Oct 1;2018(10):CD002252. doi: 10.1002/14651858.CD002252.pub4

South Africa 1991a.

Methods Allocation concealment: cards labelled R and Q picked blindly from a box, these identified drug container. Two arms
Participants 32 women at 12 to 30 weeks' gestation with a singleton pregnancy and BP >/= 140/90 mmHg x 2 at least 6 hrs apart, no proteinuria, no antihypertensive therapy and no other drug treatment.
Interventions Exp: oral prazosin 1 mg to 5 mg x 3/day. (12 women)
 Control: oral identical placebo. (20 women)
Outcomes Women: severe HT, proteinuria, duration of treatment, placental abruption, caesarean section.
 Babies: perinatal death, gestation at delivery (mean), birthweight, SGA (< 10th centile) preterm delivery (< 37 weeks).
Notes Method for measuring BP not mentioned. The trial stopped early.
Funding: no information about funding source.
Declaration of interests not described.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not described.
Allocation concealment (selection bias) Unclear risk Not described. Quote: "...in a randomised way, participants either received...". No further details.
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk Although identical placebo tablets were used, there is no information about whether it was a double‐blind or a single‐blind trial.
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Not described.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk No.
Selective reporting (reporting bias) Unclear risk Assessment from published study report.
Other bias Unclear risk No information about funding source. Declaration of interests not described.